Neonatal screening for congenital hypothyroidism in the Netherlands: Cognitive and motor outcome at 10 years of age

Autor: Thomas Vulsma, Martha A. Grootenhuis, Jan J. M. de Vijlder, Bob F. Last, Brenda M. Wiedijk, Libbe Kooistra, Caren I. Lanting, Ria W. G. Nijhuis-van der Sanden, Liesbeth van der Sluijs Veer, Marlies J. E. Kempers
Přispěvatelé: Clinical Developmental Psychology, Child and Adolescent Psychiatry & Psychosocial Care, Other Research, CCA -Cancer Center Amsterdam, APH - Amsterdam Public Health, Paediatric Endocrinology, TNO Kwaliteit van Leven
Jazyk: angličtina
Rok vydání: 2006
Předmět:
Zdroj: Journal of Clinical Endocrinology and Metabolism, 912(3). Oxford University Press
Journal of Clinical Endocrinology and Metabolism, 92, 919-24
Journal of clinical endocrinology and metabolism, 92(3), 919-924. The Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 92, 3, pp. 919-24
Kempers, M J, van der Sluijs-Veer, L, Nijhuis-van der Sanden, M W, Lanting, C I, Kooistra, L, Wiedijk, M, Last, B F, de Vijlder, J J, Grootenhuis, M A & Vulsma, T 2006, ' Neonatal screening for congenital hypothyroidism in the Netherlands: Cognitive and motor outcome at 10 years of age ', Journal of Clinical Endocrinology and Metabolism, vol. 912, no. 3, pp. 919 . https://doi.org/10.1210/jc.2006-1538
Journal of Clinical Endocrinology and Metabolism, 3, 92, 919-924
ISSN: 0021-972X
Popis: Context: Patients with thyroidal congenital hypothyroidism (CH-T) born in The Netherlands in 1981–1982 showed persistent intellectual and motor deficits during childhood and adulthood, despite initiation of T4 supplementation at a median age of 28 d after birth. Objective: The present study examined whether advancement of treatment initiation to 20 d had resulted in improved cognitive and motor outcome. Design/Setting/Patients: In 82 Dutch CH-T patients, born in 1992 to 1993 and treated at a median age of 20 d (mean, 22 d; range, 2–73 d), cognitive and motor outcome was assessed (mean age, 10.5 yr; range, 9.6–11.4 yr). Severity of CH-T was classified according to pretreatment free T4 concentration. Main Outcome Measure: Cognitive and motor outcome of the 1992–1993 cohort in comparison to the 1981 to 1982 cohort was the main outcome measure. Results: Patients with severe CH-T had lower full-scale (93.7), verbal (94.9), and performance (93.9) IQ scores than the normative population (P < 0.05), whereas IQ scores of patients with moderate and mild CH-T were comparable to those of the normative population. In all three severity subgroups, significant motor problems were observed, most pronounced in the severe CH-T group. No correlations were found between starting day of treatment and IQ or motor outcome. Conclusions: Essentially, findings from the 1992–1993 cohort were similar to those of the 1981–1982 cohort. Apparently, advancing initiation of T4 supplementation from 28 to 20 d after birth did not result in improved cognitive or motor outcome in CH-T patients.
Databáze: OpenAIRE